Secobarbital

Drugs of abuse screening, forensic toxicology investigations, postmortem toxicology, clinical toxicology assessments, and medical aid-in-dying cases in jurisdictions with legalized assisted death all require detection of secobarbital, a Schedule II barbiturate historically used as a sedative-hypnotic and pre-anesthetic agent. UTAK’s Barbiturates Panel and STABBS panels contain secobarbital in lyophilized serum and urine matrices at multiple concentration levels, supporting both immunoassay screening and confirmation methods. Stock and custom QC solutions can incorporate related barbiturates such as phenobarbital, pentobarbital, amobarbital, butalbital, and other commonly monitored sedative-hypnotics to address your laboratory’s comprehensive barbiturate and drugs of abuse testing requirements.